20/20 Biolabs, Inc.
AIDX· Nasdaq
AIDX20/20 Biolabs, Inc.
Quarterly figures for 20/20 Biolabs, Inc., with source filings when available.
4 quarters. Mar 31, 2025 to Jun 30, 2026. USD.
20/20 Biolabs, Inc. has filed its 10-Q within 45 to 50 days of period end across its last 2 quarters. Few filings are on file, so the projected window is widened until the pattern is clear.
20/20 Biolabs, Inc. · CIK 1139685 · Engraved from SEC EDGAR
